BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30710281)

  • 21. S100A1 and S100B interactions with annexins.
    Garbuglia M; Verzini M; Hofmann A; Huber R; Donato R
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):192-206. PubMed ID: 11108963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines.
    Sorci G; Agneletti AL; Donato R
    Neuroscience; 2000; 99(4):773-83. PubMed ID: 10974440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
    Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
    J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution structure of S100A1 bound to the CapZ peptide (TRTK12).
    Wright NT; Cannon BR; Wilder PT; Morgan MT; Varney KM; Zimmer DB; Weber DJ
    J Mol Biol; 2009 Mar; 386(5):1265-77. PubMed ID: 19452629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filaments.
    Garbuglia M; Verzini M; Sorci G; Bianchi R; Giambanco I; Agneletti AL; Donato R
    Braz J Med Biol Res; 1999 Oct; 32(10):1177-85. PubMed ID: 10510252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.
    Khan MI; Su YK; Zou J; Yang LW; Chou RH; Yu C
    PLoS One; 2018; 13(2):e0190545. PubMed ID: 29444082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain.
    Matsumura H; Shiba T; Inoue T; Harada S; Kai Y
    Structure; 1998 Feb; 6(2):233-41. PubMed ID: 9519413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization.
    Osterloh D; Ivanenkov VV; Gerke V
    Cell Calcium; 1998 Aug; 24(2):137-51. PubMed ID: 9803314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B.
    Sorci G; Bianchi R; Giambanco I; Rambotti MG; Donato R
    Cell Calcium; 1999 Feb; 25(2):93-106. PubMed ID: 10326676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis.
    Wilder PT; Baldisseri DM; Udan R; Vallely KM; Weber DJ
    Biochemistry; 2003 Nov; 42(46):13410-21. PubMed ID: 14621986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimane- and acrylodan-labeled S100 proteins. Role of cysteines-85 alpha and -84 beta in the conformation and calcium binding properties of S100 alpha alpha and S100b (beta beta) proteins.
    Baudier J; Glasser N; Duportail G
    Biochemistry; 1986 Nov; 25(22):6934-41. PubMed ID: 3801403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100B and S100A1 proteins in bovine retina:their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry.
    Rambotti MG; Giambanco I; Spreca A; Donato R
    Neuroscience; 1999; 92(3):1089-101. PubMed ID: 10426548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy.
    Drohat AC; Amburgey JC; Abildgaard F; Starich MR; Baldisseri D; Weber DJ
    Biochemistry; 1996 Sep; 35(36):11577-88. PubMed ID: 8794737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular modeling of single polypeptide chain of calcium-binding protein p26olf from dimeric S100B(betabeta).
    Tanaka T; Miwa N; Kawamura S; Sohma H; Nitta K; Matsushima N
    Protein Eng; 1999 May; 12(5):395-405. PubMed ID: 10360980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.
    Kraus C; Rohde D; Weidenhammer C; Qiu G; Pleger ST; Voelkers M; Boerries M; Remppis A; Katus HA; Most P
    J Mol Cell Cardiol; 2009 Oct; 47(4):445-55. PubMed ID: 19538970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for the interaction between stress-inducible phosphoprotein 1 (STIP1) and S100A1.
    Maciejewski A; Prado VF; Prado MAM; Choy WY
    Biochem J; 2017 May; 474(11):1853-1866. PubMed ID: 28408431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping.
    Ostendorp T; Diez J; Heizmann CW; Fritz G
    Biochim Biophys Acta; 2011 May; 1813(5):1083-91. PubMed ID: 20950652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C.
    Baudier J; Mochly-Rosen D; Newton A; Lee SH; Koshland DE; Cole RD
    Biochemistry; 1987 May; 26(10):2886-93. PubMed ID: 3111527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox modifications of the C-terminal cysteine residue cause structural changes in S100A1 and S100B proteins.
    Zhukova L; Zhukov I; Bal W; Wyslouch-Cieszynska A
    Biochim Biophys Acta; 2004 Dec; 1742(1-3):191-201. PubMed ID: 15590070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divalent metal ion complexes of S100B in the absence and presence of pentamidine.
    Charpentier TH; Wilder PT; Liriano MA; Varney KM; Pozharski E; MacKerell AD; Coop A; Toth EA; Weber DJ
    J Mol Biol; 2008 Sep; 382(1):56-73. PubMed ID: 18602402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.